ATI RN
ATI RN Pharmacology 2023 V Questions
Extract:
Question 1 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: B
Rationale: The correct answer is B: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs).
Therefore, monitoring the WBC count is crucial to evaluate the effectiveness of the treatment. An increase in WBC count indicates that the filgrastim is working to boost the immune system.
Incorrect
Choices:
A: INR - INR measures blood clotting time and is not directly related to the effectiveness of filgrastim.
C: BUN - BUN assesses kidney function, which is not affected by filgrastim.
D: Potassium level - Potassium is not typically affected by filgrastim therapy.
Question 2 of 5
A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client responding to the treatment?
Correct Answer: B
Rationale: The correct answer is B: Decreased ascites. Spironolactone is a diuretic commonly used to treat fluid retention in patients with cirrhosis. Ascites is the accumulation of fluid in the abdominal cavity, a common complication of liver cirrhosis. Improvement in ascites indicates that the spironolactone is effectively reducing fluid retention. Decreased jaundice (choice
A) is not directly related to spironolactone use. Increased energy (choice
C) and increased appetite (choice
D) are subjective and nonspecific findings that do not directly indicate response to spironolactone in treating ascites.
Question 3 of 5
A nurse is assessing the vital signs of a client who is taking amiodarone. The nurse should anticipate which of the following findings as an adverse effect of the medication?
Correct Answer: B
Rationale: The correct answer is B: Bradycardia. Amiodarone is an antiarrhythmic medication that can cause bradycardia as an adverse effect due to its action on the heart's electrical conduction system. This can lead to a slow heart rate, which the nurse should monitor for. The other choices are incorrect because hypertension (
A) is not a common adverse effect of amiodarone, fever (
C) is not typically associated with this medication, and bradypnea (
D) refers to slow breathing rate, which is not a typical adverse effect of amiodarone.
Question 4 of 5
A nurse is preparing to mix short-acting insulin with NPH insulin from two vials. Which of the following actions should the nurse take?
Correct Answer: D
Rationale: The correct answer is D: Inject air into the vial to withdraw the short-acting insulin. This step is necessary to prevent creating a vacuum in the vial, which can make it difficult to withdraw the insulin. By injecting air into the vial before withdrawing the short-acting insulin, the nurse ensures smooth and accurate extraction of the medication. Using two separate syringes (choice
A) is unnecessary as long as the nurse follows proper technique. Ensuring NPH insulin is drawn first (choice
B) is not necessary and may lead to errors in dosage. Administering the insulin within 20 minutes (choice
C) is not relevant to the preparation process.
Question 5 of 5
A nurse is providing teaching to a client about how to self-administer subcutaneous injections of enoxaparin. Which of the following instructions should the nurse include?
Correct Answer: C
Rationale: The correct answer is C: Ensure that the air bubble remains in the syringe. This is important because enoxaparin is an anticoagulant medication and should be injected without removing the air bubble to ensure the full dose is administered.
Choice A is incorrect as enoxaparin should be injected into the abdomen, not the lateral thigh.
Choice B is incorrect because the skin fold should be held during the injection to ensure proper administration.
Choice D is incorrect as rubbing the site after injection can cause bruising or irritation.